VTRS

Viatris Inc Ord Shs

16.94

-0.08-0.44%

Opening11:53 07/23 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE16.83/17.01

TODAY RANGE16.76-17.04

VOL1.65M

MARKET CAP19.72B

52 WEEK RANGE8.30-17.68

AVG VOL (3M)11.09M

% TURNOVER0.14%

TURNOVER--

P/E (TTM)-65.4114

% RANGE1.68%

EPS(TTM)-0.2589

P/E(FORWARD)128.38

P/B1.345

BVPS12.59

DIVIDEND0.4800

P/S1.363

BETA--

DIV YIELD2.83%

FREE FLOAT MKT CAP19.66B

SHARES OUTSTANDING1.16B

NEXT EARNINGS08/05-08/10

FREE FLOAT1.16B

LOT SIZE1

EX-DATE05/22/2026

News

Press Releases

Financial Reports

Profile

Seeking Alpha·1d ago
Trump outlines plans for up to 200% tariffs on generic drug imports starting in 2028
TipRanks·1d ago
UBS Reaffirms Their Buy Rating on Viatris (VTRS)
NASDAQ·07/15 14:48
Noteworthy ETF Inflows: IHE, VTRS, RPRX, ZTS
Reuters·07/14 12:54
RPT-MYLAN INC SELLS 46 MLN BIOCON SHARES FOR 400 RUPEES/SHARE VIA BLOCK DEALS - BSE DATA
Seeking Alpha·07/14 11:34
Organon & Co: Great Odds, Small Prize, Big Penalty
Reuters·07/14 06:02
BUZZ-Indian shares drop as Trump's Hormuz levy threat drags risk sentiment
Reuters·07/14 04:04
BUZZ-India's Biocon gains after block deal
Reuters·07/13 13:43
UPDATE 2-Mylan to sell up to $363 million stake in India's Biocon, term sheet shows
TipRanks·07/10 10:36
Bank of America Securities Keeps Their Sell Rating on Viatris (VTRS)
TipRanks·07/01 21:10
Viatris Secures New ¥40 Billion Term Loan Facility
Reuters·07/01 20:24
VIATRIS - SECURES ¥40 BLN SENIOR UNSECURED TERM LOAN FACILITY - SEC FILING
PUBT·07/01 20:21
Viatris enters amended ¥40 billion term loan credit agreement with Mizuho Bank-led lenders
PUBT·07/01 10:59
Viatris schedules second-quarter 2026 earnings report and conference call
PR Newswire·07/01 10:59
Viatris to Report Second-Quarter 2026 Financial Results on August 6, 2026
NASDAQ·07/01 10:00
Biotech Stocks Facing FDA Decision In July 2026

Same Industry

Name/Symbol

Change%

Price

VTRS

MCK

Biogen Inc

BIIB

-0.84%

204.26

AMGN

SHPG

CELG-RT

Lilly Eli & Co

LLY

-2.22%

Celgene

CELG

0.00%

108.24

Therapeuticsmd Inc

TXMD

+0.98%

2.060

Johnson & Johnson

JNJ

-1.67%

248.82

Abbvie Inc

ABBV

-0.44%

253.38

ZTS

GILD

Novo-Nordisk A/S

NVO

-2.25%

50.32

Bristol-Myers Squibb Co

BMY

+0.38%

60.74

Alexion Pharms

ALXN

+1.70%

182.50

Pfizer

PFE

-0.46%

24.94

SNY

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

-2.73%

149.56

RDY

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.